Ellie Mae (ELLI) Tanks on Earnings Miss, Lowered Forecast

Jacob Harper |

Ellie Mae Inc. ($ELLI) the “leading provider of on-demand automation solutions for the mortgage industry,” reported earnings after the bell on Oct. 31, and they were a severe disappointment. The company missed on revenue and profit, and significantly lowered projections for the fourth quarter. The company’s shares fell in direct response.



In a conference call with investors, founder and CEO Sig Alderman said the earnings were below expectations for three reasons. One, mortgage applications steeply declined. Two, it was taking longer to implement orders from larger customers who signed on earlier in the year. Three, the company was negatively impacted by “two re-fi focused customers going out of business during the quarter.”

But the mortgage software company’s earnings miss is not expected to be a one-time thing. The company also lowered internal estimates for fourth quarter net gain to $0.17 to $0.18 a share, down from the $0.24 expected by analysts.

Ellie Mae has reportedly been looking for a white knight since August, interviewing banks to possibly organize a sale of the company.

For their third quarter 2013 earnings report, Ellie Mae reported a net gain of $3.36 million, or $0.12 per share, versus the net gain of $6.83 million, or $0.25 per share, from the same period a year ago. Revenue for the quarter was $33 million, as compared to $27.5 million from the previous year. Analysts were expecting a net gain of $0.30 per share on revenues of $34.4 million.

On the earnings miss and lowered forecast Ellie Mae’s shares fell precipitously, losing 17.51 percent in midday trading to hit $23.81 a share.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ELLI Ellie Mae Inc. 82.42 0.01 0.01 805,749
CDEX Cdex Inc A 0.00 0.00 73.91 17,331

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…